GET DAILY SIGNALSZenaTech (ZENA) Stock Falls -38% in 30 Days on Dilution Concerns
Key Takeaways
- ZenaTech (ZENA) shares declined roughly 38% over the last 30 days, falling from about $1.09 to near $0.68.
- The move was driven primarily by equity dilution concerns after the company more than doubled its at-the-market (ATM) offering program to $150 million.
- Rapid revenue growth — up 425% year over year in the first half of 2026 — has been outweighed by widening net losses and negative operating cash flow.
- The stock trades near the low end of its 52-week range with unusually high volatility, reflected in a beta near 7.5.
- Over the last quarter, shares fell more than 60%, extending a longer downtrend from the stock's 52-week high.
- For deeper insight into this ticker's outlook, explore ZenaTech's Price Targets, Earnings, and Forecast pages.
- Explore Trending AI Robots to see top-performing AI trading bots relevant to this name.
Understanding ZenaTech’s Business and Market Position
ZenaTech, Inc. is a Vancouver, Canada-based technology company specializing in artificial-intelligence autonomy and drone platforms for industrial, government, and defense markets. The business operates through several subsidiaries, including ZenaDrone, which designs and manufactures drones, a global Drone-as-a-Service (DaaS) division, and a separate enterprise SaaS segment with multiple software brands.
The company's hardware portfolio spans the ZenaDrone 1000 for ISR and cargo applications, the IQ Series drones (Nano, Square, Quad, and Aqua) for indoor inventory, inspection, surveying, and underwater applications, and emerging counter-UAS systems such as the Interceptor P-1. ZenaTech is executing an acquisition-led DaaS roll-up strategy, purchasing land surveying, inspection, and power-washing businesses and converting them to drone-based delivery to build recurring revenue. Investors follow the stock for its exposure to the fast-growing commercial and defense drone markets, its pursuit of Green UAS and Blue UAS certifications, and its NDAA-compliant manufacturing expansion in Mesa, Arizona. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Stock Price Performance: Last 30 Days vs. Quarter
Over the last 30 days, ZENA shares have fallen approximately 38%, sliding from about $1.09 to roughly $0.68. The decline was not linear: the stock broke below $1.00 in late October and reached a low near $0.58 in early November before a modest rebound.
The quarterly trend has been even more pronounced. Since mid-August, when shares traded around $1.82, the stock has declined more than 60%. This extends a longer downtrend from the 52-week high of $5.17, with the stock now trading near the bottom of its range. The persistent selling pressure reflects a broader de-rating of speculative, high-beta small-cap AI and drone names, combined with company-specific dilution and profitability concerns.
What Drove the 30-Day Decline in ZENA
The dominant catalyst for the 30-day decline was a sharp escalation in equity dilution. In early October, ZenaTech filed a prospectus supplement that increased its at-the-market offering program from $75 million to $150 million, after having already raised approximately $57 million through the sale of roughly 29.7 million shares. The expanded share issuance program — with substantial capacity still available — reignited investor concerns about future dilution and weighed heavily on the stock.
Dilution concerns compounded an already difficult fundamental backdrop. While the company reported preliminary third-quarter revenue guidance of C$13.4 million to C$14.8 million and strong sequential growth, it continued to post significant net losses and negative operating cash flow. Mounting cash burn, a growing share count, and repeated equity raises have led the market to discount rapid top-line growth in favor of profitability risk. The stock's high beta near 7.5 has amplified selling during periods of broader risk-off sentiment in speculative technology names. From what I see, this dynamic is common in high-growth but unprofitable names.
Quarterly Trends and the Broader Narrative
Over the last quarter, the broader narrative has centered on the tension between aggressive, acquisition-fueled revenue growth and deteriorating per-share economics. ZenaTech completed numerous acquisitions and reported triple-digit revenue increases, but each round of funding — including a $25 million registered direct offering earlier in the year and the enlarged ATM program — added to the share count and pressured the stock.
Persistent operating losses, negative cash flow, and auditor and market scrutiny around the sustainability of the roll-up strategy have kept sentiment subdued. The stock's decline from its 52-week high reflects a repricing of the company's growth story as investors demand clearer evidence of a path toward profitability rather than continued dilution-funded expansion. One thing that stands out is how quickly the market has shifted focus from top-line momentum to balance-sheet concerns.
What Investors Should Watch Next
Several factors will likely shape ZenaTech's near-term trajectory. Investors should monitor the company's upcoming third-quarter results for confirmation of its preliminary revenue range and any updates on the path toward adjusted EBITDA breakeven, a target management has set for 2027. The pace and terms of further ATM share sales, along with any additional acquisitions, will remain central to the dilution story.
Progress on Green UAS and Blue UAS certifications, defense demonstrations, and commercialization of newer products such as the counter-UAS platforms and the ZenaWorx construction-monitoring software will be important catalysts. Macroeconomic conditions, including interest rates and risk appetite toward speculative small-caps, may also influence volatility. As with any high-growth, loss-making company, the key question remains whether revenue expansion can translate into improving margins and sustainable cash flow. I’m watching this closely as the next few quarters could clarify the picture.
Integrating AI Tools Into My Research Process
When analyzing names like this, I often turn to Tickeron’s platform for additional perspective. The AI Daily Buy/Sell Signals and AI Trading Bots help me cross-check momentum and pattern data against broader market activity. These tools provide a systematic layer that complements fundamental work, especially for volatile small-caps where sentiment can shift quickly. In my view, combining them with traditional analysis offers a more balanced view without replacing core due diligence.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
ZENA in +9.56% Uptrend, growing for three consecutive days on November 10, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where ZENA advanced for three days, in 69 of 82 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
ZENA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ZENA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for ZENA entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 46 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.558) is normal, around the industry mean (16.360). P/E Ratio (-0.383) is within average values for comparable stocks, (53.310). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.696). Dividend Yield (0.000) settles around the average of (0.434) among similar stocks. P/S Ratio (4.342) is also within normal values, averaging (104.492).
The Tickeron Price Growth Rating for this company is 94 (best 1 - 100 worst), indicating slightly worse than average price growth. ZENA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZENA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry ComputerCommunications
Advertisement